Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Increlex in Duchenne Muscular Dystrophy
NCT01207908Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Nov 2010
- Primary completion
- Oct 2012
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of mecasermin in Duchenne muscular dystrophy (DMD), sponsored by Cincinnati Children's Hospital Medical Center. Started Nov 2010; status: completed.
02
Drugs
mecasermin
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01207908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207908.